BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9437823)

  • 1. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs.
    Bourdoiseau G; Bonnefont C; Hoareau E; Boehringer C; Stolle T; Chabanne L
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):21-30. PubMed ID: 9437823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites.
    Deplazes P; Smith NC; Arnold P; Lutz H; Eckert J
    Parasite Immunol; 1995 Sep; 17(9):451-8. PubMed ID: 8552413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis.
    Guarga JL; Moreno J; Lucientes J; Gracia MJ; Peribáñez MA; Castillo JA
    Vet Immunol Immunopathol; 2002 Sep; 88(1-2):13-20. PubMed ID: 12088640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
    Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S
    Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
    Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M
    Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.
    Miret J; Nascimento E; Sampaio W; França JC; Fujiwara RT; Vale A; Dias ES; Vieira E; da Costa RT; Mayrink W; Campos Neto A; Reed S
    Vaccine; 2008 Mar; 26(12):1585-94. PubMed ID: 18328956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis.
    Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P
    Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune responses in dogs with inapparent natural Leishmania infantum infection.
    Coura-Vital W; Marques MJ; Giunchetti RC; Teixeira-Carvalho A; Moreira ND; Vitoriano-Souza J; Vieira PM; Carneiro CM; Corrêa-Oliveira R; Martins-Filho OA; Carneiro M; Reis AB
    Vet J; 2011 Nov; 190(2):e43-e47. PubMed ID: 21596598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the Leishmania infantum-specific antibody repertoires and the autoantibody repertoires between asymptomatic and symptomatic dogs.
    Chaabouni A; Boubaker Elandoulsi R; Mhadhbi M; Gharbi M; Sassi A
    Vet Parasitol; 2018 Sep; 261():9-17. PubMed ID: 30253856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subset abnormalities in canine leishmaniasis.
    Bourdoiseau G; Bonnefont C; Magnol JP; Saint-André I; Chabanne L
    Vet Immunol Immunopathol; 1997 May; 56(3-4):345-51. PubMed ID: 9223238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis.
    Martínez-Moreno A; Moreno T; Martínez-Moreno FJ; Acosta I; Hernández S
    Vet Immunol Immunopathol; 1995 Oct; 48(3-4):209-20. PubMed ID: 8578681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Western blotting in the clinical follow-up of canine leishmaniasis.
    Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM
    J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of Leishmania infantum naturally infected dogs treated with allopurinol: immunofluorescence antibody test, ELISA and Western blot.
    Vercammen F; Fernandez-Perez FJ; del Amo C; Alunda JM
    Acta Trop; 2002 Dec; 84(3):175-81. PubMed ID: 12443795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs.
    Cardoso L; Schallig HD; Cordeiro-da-Silva A; Cabral M; Alunda JM; Rodrigues M
    Vet Immunol Immunopathol; 2007 May; 117(1-2):35-41. PubMed ID: 17321602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment.
    Rodríguez A; Solano-Gallego L; Ojeda A; Quintana J; Riera C; Gállego M; Portús M; Alberola J
    J Vet Intern Med; 2006; 20(3):495-8. PubMed ID: 16734080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
    Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
    Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment.
    Mancianti F; Gramiccia M; Gradoni L; Pieri S
    Trans R Soc Trop Med Hyg; 1988; 82(4):566-7. PubMed ID: 3076714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
    Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
    Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
    Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M
    Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.